Blog

Now, in the challenging context of the COVID-19 crisis we want to help share the load and use our expertise to support healthcare professionals who battle the virus on the frontlines.

New technologies such as data mining, cloud computing, etc. must be used to uncover live-saving insights into this plethora of data. The question is: Can hospitals use these novel techniques to analyze this data? And is the GDPR an obstacle in this process?

Outcome measurement in Orthopaedics has had increasing importance over the past few years. This trend has long been present in the US and in some European countries (e.g. Belgium and the Netherlands).

A clinician’s central goal is to help his patients: cure their illnesses, ease their discomfort, and help them manage their health overall. However, doing this more effectively and efficiently requires outcomes data.

LynxCare had the opportunity to attend the exciting AIMed North America Conference that was held in Dana Point, CA from the 13th until the 15th of December 2018

During the past few months, Amaron has held negotiations with a number of companies in order to establish sustainable partnerships. We, at LynxCare, are proud to be one of these partners.

LynxCare attended the AI & Big Data Expo North America, the leading Artificial Intelligence & Big Data Conference & Exhibition which took place on November 28-29 at the Santa Clara Convention Center, Silicon Valley.

AIMed provides year-round education and networking opportunities for clinicians, solution-providers and thought-leaders alike through a series of international events, brochures and online content.

Under the value-based care agreements, providers are rewarded for collecting and improving outcomes. This shift has led to a more patient-centric approach as it collects outcome data that matter most to the patients.